Sign in

CIK 0000944809

  • Accelerated filer

OPKO HEALTH, INC.

Sign in to watch
Ticker
OPK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
752402409
Phone
+1 305-575-4181
Business address
4400 BISCAYNE BLVD., MIAMI, FL, 33137
Former names
EXEGENICS INC, eXegenics Inc, CYTOCLONAL PHARMACEUTICS INC /DE
  1. 4 Open-market buy CEO & Chairman bought 100,000 shares at an average $1.76 ($175,804)
  2. 4 Open-market buy CEO & Chairman bought 75,000 shares at an average $1.75 ($131,260)
  3. 4 Open-market buy CEO & Chairman bought 100,000 shares at an average $1.82 ($181,752)
  4. 4 Open-market buy CEO & Chairman bought 650,000 shares at an average $1.84 ($1,194,998)
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Open-market buy Chief Innovation Officer bought 460,245 shares at an average $1.83 ($840,899)
  19. 4 Grant or award 10% owner acquired 23,148,148 shares (grant or award)
  20. 4 Open-market buy CEO & Chairman bought 200,000 shares at an average $1.32 ($264,294)

Page 6 of 106 · 2,118 filings